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The biological mechanisms by which EVOO and nuts, main components of the MedDiet intervention in PREDIMED, 6 protect against CVD remain to be uncovered. Both foods have a favorable fatty acid profile. 7, 8 Their richness in bioactive phytochemicals with antioxidant and anti-inflammatory properties probably explains why their consumption decreases circulating inflammatory biomarkers related to atherogenesis. 9 Thus, it is plausible that EVOO and nuts might reduce CVD via an antiatherogenic effect, thus delaying the development of atherosclerosis, the pathological basis of most CVD events.
Artery vessel wall enlargement, an early feature of atherosclerosis, can be easily evaluated by ultrasound determination of carotid artery intima-media thickness (IMT), a noninvasive, well-standardized, and validated imaging technique. 10 IMT has been usually measured in the common carotid artery (CCA) because this carotid segment is easily visualized and Data are expressed as mean (95% confidence interval) except for quantitative variables, expressed as n (%). BIF-IMT indicates intima-media thickness of bifurcation; BMI, body mass index; CCA-IMT, intima-media thickness of common carotid artery; CVD, cardiovascular disease; EVOO, extra virgin olive oil; HDL, high-density lipoprotein; ICA-IMT, intima-media thickness of internal carotid artery; LDL, low-density lipoprotein; MedDiet, Mediterranean diet; and MET-min, minutes at a given metabolic equivalent level (units of energy expenditure in physical activity, 1 MET-min is roughly equivalent to 1 kcal). *χ 2 test and ANOVA, as appropriate. †Adjusted for sex, age, ever smoking, BMI, energy intake, use of statins, use of antidiabetic drugs, and use of antihypertensive drugs. ‡Measured in 155 participants (n=58, n=55, and n=42, respectively). §Measured in subjects with focal intrusions into the lumen ≥1.2-mm thick (n=46, n=46, and n=34, respectively).
CCA-IMT is a more reproducible measure than IMT of other carotid segments, such as the bifurcation or internal carotid artery (ICA). 11 CCA-IMT has been widely used as a surrogate marker of future coronary events, 12 but there is increasing evidence that maximum ICA-IMT and particularly carotid plaque are more representative of atherosclerosis and better predict CVD than CCA-IMT. 13, 14 In a prior PREDIMED substudy, participants with a high carotid atherosclerotic burden allocated to the MedDiets supplemented with either EVOO or nuts showed regression of mean CCA-IMT at 1 year compared with those assigned to the control diet. 15 However, changes in IMT of other carotid segments or plaque were not investigated in that study. We hypothesized that, in subjects at high vascular risk participating in the PREDIMED study, MedDiets supplemented with EVOO or nuts for >2 years would favorably influence the carotid lesions that best predict CVD risk, namely maximum ICA-IMT and plaque height.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
All 200 participants successfully underwent baseline ultrasound measurements of carotid IMT and plaque, but 25 participants refused to undergo a second procedure. No significant differences were observed between the refusers and compliers in terms of baseline clinical characteristics, lipid profiles, treatment regimes, and sonographic variables (data not shown). Complete clinical and ultrasound information was available in 164 participants after intervention for a mean of 2.4 years (range, 1.6-3.1 years).
Participants in the 3 groups were well balanced for baseline clinical characteristics ( Table 1 ). As shown in Table 2 †Determined by 12 questions on food consumption frequency and 2 questions on food intake habits characteristic of the Mediterranean diet (each question scored 0 or 1). g/d]), reflecting the fat composition of supplemental nuts, but also an increased adherence to the MedDiet. In spite of supplemental EVOO, monounsaturated fatty acid intake did not increase in the corresponding MedDiet group because participants replaced customarily used common olive oil by the extra virgin variety supplied. Subjects in the 3 groups reported similar baseline adherence to the MedDiet, but the 14-item score improved only in the 2 MedDiet groups. No between-group differences in consumption of fruits, vegetables, cereals, meats, dairy products, desserts, or alcohol were observed (data not shown).
No between-group differences were observed in changes of weight, waist circumference, systolic and diastolic blood pressure, fasting glucose, or the lipid profile. Similarly, no differences were seen regarding the incidence of diabetes mellitus or metabolic syndrome. The Figure depicts (Table 3) .
When comparing baseline and the time point closest to the second sonographic measurement (Table 4) , changes in objective biomarkers were mean increases from baseline to end of the trial of 0.10% for plasma α-linolenic acid in the MedDiet with nuts group and of 337 μg/L in urinary hydroxytyrosol in the MedDiet with EVOO group (P=0.003 versus control diet group for both), respectively, indicating good compliance with the supplemental foods. Attesting to the validity of the food frequency questionnaire, the Pearson correlation coefficient between changes in plasma α-linolenic acid and calculated dietary intake of α-linolenic acid was 0.263 (P=0.024). Likewise, the plasma change of α-linolenic acid was significantly correlated to changes in walnut and total nut intake (r=0.410, P≤0.001 and r=0.374, P=0.001, respectively). Changes in urinary hydroxytyrosol showed a borderline significant correlation with changes in EVOO intake (r=0.236; P=0.088). Table 5 shows the independent determinants of change in plaque max (millimeters). As seen, allocation into the MedDiet+nuts group versus the control diet group (B=−0.198 [95% confidence interval, −0.343 to −0.054]), use of antihypertensive drugs at baseline (0.132 [0.001 to 0.263]), and baseline plaque max (−0.137 [−0.217 to −0.057]) were the only variables significantly associated with changes in plaque max (R 2 =0.122).
Discussion
In this randomized clinical trial conducted in subjects at high cardiovascular risk but no CVD at enrollment, we found that, compared with a control group based on advice to follow a low-fat diet, intervention with a MedDiet supplemented with 30 g/d of mixed nuts for a mean of 2.4 years induced regression of ICA-IMT mean and delayed the progression of both ICA-IMT max and plaque max , the ultrasound features that best predict future CVD events. [12] [13] [14] Although ICA-IMT max and plaque max progressed in the control group, there were no changes in the MedDiet supplemented with EVOO group. A consistent body of evidence, mostly from prospective studies, points to the MedDiet as the dietary pattern most beneficial for cardiovascular health. 3 The richness of the plantbased MedDiet in potentially beneficial foods, such as fruit, vegetables, legumes, nuts, cereals, and olive oil, is believed to explain its cardioprotective effects. 4, 9 Our results reinforce the notion that a MedDiet enriched with tree nuts could be a sound strategy to delay the progression of atherosclerosis, the harbinger of future cardiovascular events.
A recent report from the PREDIMED study has shown that MedDiets supplemented with either EVOO or nuts reduce incident CVD events compared with advice on a low-fat diet. Of note, the MedDiet with nuts was also associated with a significant 49% reduction in risk of stroke. 6 Our findings of delayed IMT progression and, more importantly, delayed plaque progression might explain in part the reduction of CVD events, particularly stroke, observed in the arm supplemented with nuts in the PREDIMED trial. This adds evidence to that collected in earlier reports of the PREDIMED trial on the salutary effects of the enhanced MedDiets on traditional cardiovascular risk factors 16 ; novel risk factors, such as markers of oxidation, inflammation, or endothelial dysfunction 16, 17 ; circulating immune cell activation 18 ; and the incidence of high cardiovascular risk conditions, namely the metabolic syndrome 19 and diabetes mellitus. 20 Mean baseline IMT values at all carotid segments were close to those reported for Southern European subjects of similar age and cardiovascular risk in an ecological study conducted in 5 European countries, 21 which concurs with reportedly low IMT values in Mediterranean areas compared with Northern Europe, a geographical gradient of carotid IMT similar to that observed for CVD risk. 1, 2 In this regard, our findings of reduced IMT progression with enhanced MedDiets suggest that nutritional factors might play a role in delaying the progression of atherosclerosis in Southern Europe. Few clinical trials have examined the effects of the MedDiet on IMT progression. 15, 22 In the Dietary Intervention Randomized Controlled Trial-Carotid study, 22 carotid IMT was determined before and after 2 years of nutrition intervention with 3 weight-loss diets, including 1 MedDiet arm. Participants were younger, mostly male, and had a lower baseline IMT. No significant IMT changes were observed, but regression of carotid vessel wall volume was documented, suggesting an antiatherosclerotic effect.
Because of physiological and mechanical reasons (blood flow velocity and shear stress), the various carotid segments are differently prone to atherosclerosis. In this sense, CCA-IMT is taken as a measure of early atherosclerosis when enlarged, whereas ICA-IMT increases are more representative of advanced atherosclerosis. Therefore, the beneficial effect on ICA-IMT rather than CCA-IMT suggests that if bioactive components of the MedDiet with nuts (such as polyunsaturated fatty acids, arginine, and beneficial minerals such as calcium, potassium, and magnesium 23 ) prevent cardiovascular events, 6 they must do so in part by delaying the progression of atherosclerotic disease in critical arterial beds rather than Table 3 *Obtained by ANCOVA adjusted for sex, age, ever smoking, body mass index, energy intake, use of statins, use of antidiabetic drugs, and use of antihypertensive drugs at baseline, follow-up time, and in-trial changes in statin dose standardized to simvastatin. by preventing its onset. We found that baseline plaque height had the strongest association with the change in plaque max (nearly 0.14 mm regression for each millimeter of plaque height at baseline). Thus, it seems plausible that participants with a high atherosclerotic burden might be those who benefit most from the intervention, a notion put forth in a previous PREDIMED report. 15 Although reduction in height after the MedDiet with nuts suggests that plaques have been stabilized (ie, rendered less vulnerable to rupture), characterization by more precise vascular imaging techniques, such as multiple contrast magnetic resonance, 24 might provide firmer evidence.
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Table 4. Baseline Biomarkers of Adherence to Supplemental Foods and Changes by Intervention Group
Our study has limitations, such as the relatively small number of study subjects, with low statistical power to detect significant between-diet changes in cardiovascular risk factors. The small size of the sample was circumvented by the inclusion of confounding variables in the multivariate analyses, although cardiovascular risk factors and medication use were balanced between the 3 groups both at baseline and during follow-up. The main reason for a lack of a prespecified sample size is that, as far as we know, there are no published data on progression of the main outcomes (ICA-IMT max and plaque max ) in white populations that we could use to make assumptions for power calculations. The majority of clinical trials assessing changes of IMT progression with different interventions have used CCA-IMT. There are few published data on the progression of total plaque area, 25,26 but we did not measure this variable. Ours was an exploratory study with a sample large enough as to find evidence of changes in the progression of all main outcome variables between the study groups. Also, the generalization of our findings to younger and healthier individuals from other geographical locations is uncertain, even though the MedDiet has also shown cardiovascular benefit in adult US populations. 3 There are also strengths to our study, such as the evaluation of dietary adherence by objective biomarkers and the sonographic characterization of all carotid segments, important given the questionable predictive value of reduced cardiovascular events of IMT regression merely assessed at the CCA. 27, 28 In conclusion, in this randomized clinical trial conducted in subjects at high cardiovascular risk, we found that, compared with a control diet, intervention with a MedDiet supplemented with 30 g/d of nuts for a mean of 2.4 years was associated with regression or delayed progression of the surrogate markers of future CVD ICA-IMT and plaque. These findings add mechanistic evidence for the reduction of cardiovascular events observed in the arm supplemented with nuts in the PREDIMED trial. 6 Our results also suggest that a MedDiet rich in polyunsaturated fats and bioactive molecules from plant sources delays atherosclerosis progression, which likely reduces plaque vulnerability and proneness to rupture, thereby preventing ischemic events. 
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